AI assistant
Sending…
RESMED INC — Director's Dealing 2021
Nov 23, 2021
30071_dirs_2021-11-22_2e111fc9-7ce2-4bea-919c-9fa6045674e8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2021-11-18
Reporting Person: Douglas Robert Andrew (President and COO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-18 | ResMed Common Stock Options | $263.16 | A | 15252 | Acquired | 2028-11-18 | ResMed Common Stock (15252) | Direct |
Footnotes
F1: Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2022, 2023 and 2024.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29